Suzhou Basecare Medical Past Earnings Performance
Past criteria checks 0/6
Suzhou Basecare Medical has been growing earnings at an average annual rate of 37.6%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 29.7% per year.
Key information
37.6%
Earnings growth rate
67.0%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 29.7% |
| Return on equity | -13.8% |
| Net Margin | -92.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch
Mar 22
Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?
Aug 01Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop
May 26Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?
Jul 20Revenue & Expenses BreakdownBeta
How Suzhou Basecare Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 208 | -192 | 209 | 130 |
| 30 Sep 23 | 183 | -176 | 193 | 134 |
| 30 Jun 23 | 158 | -160 | 176 | 138 |
| 31 Mar 23 | 149 | -146 | 169 | 129 |
| 31 Dec 22 | 141 | -132 | 161 | 120 |
| 30 Sep 22 | 133 | -133 | 145 | 108 |
| 30 Jun 22 | 126 | -135 | 129 | 96 |
| 31 Mar 22 | 117 | -139 | 122 | 85 |
| 31 Dec 21 | 107 | -144 | 115 | 74 |
| 30 Sep 21 | 103 | -119 | 101 | 61 |
| 30 Jun 21 | 99 | -106 | 80 | 44 |
| 31 Mar 21 | 90 | -490 | 61 | 39 |
| 31 Dec 20 | 81 | -874 | 42 | 34 |
| 30 Sep 20 | 71 | -1,008 | 26 | 27 |
| 30 Jun 20 | 61 | -1,116 | 19 | 24 |
| 31 Mar 20 | 58 | -822 | 19 | 22 |
| 31 Dec 19 | 56 | -528 | 19 | 20 |
| 31 Dec 18 | 33 | -152 | 45 | 19 |
Quality Earnings: 2170 is currently unprofitable.
Growing Profit Margin: 2170 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2170 is unprofitable, but has reduced losses over the past 5 years at a rate of 37.6% per year.
Accelerating Growth: Unable to compare 2170's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2170 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.2%).
Return on Equity
High ROE: 2170 has a negative Return on Equity (-13.83%), as it is currently unprofitable.